Back to Search
DEREK RAGHAVAN, MD
MD
Medical Oncology Physician
NPI: 1912961483Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
35086068(OH)
Research & Publications (20)
Disparities in cancer care: challenges and solutions.
PMID 17474348·Oncology (Williston Park)·2007
6-review
Re: Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
PMID 17985428·Eur Urol·2007
8-other
Biological response of osteoblast-like UMR-106 cells to the modified PHBV matrix--effects of porosity and collagen dip coating.
PMID 19291684·J Biomed Mater Res A·2010
8-other
Phase II trial of neoadjuvant nab-paclitaxel in high risk patients with prostate cancer undergoing radical prostatectomy.
PMID 19230915·J Urol·2009
3-trial
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.
PMID 19213602·Lancet Oncol·2009
8-other
American society of clinical oncology policy statement: disparities in cancer care.
PMID 19403885·J Clin Oncol·2009
8-other
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
PMID 19103723·J Clin Oncol·2009
8-other
Neomycin binding preserves extracellular matrix in bioprosthetic heart valves during in vitro cyclic fatigue and storage.
PMID 19091637·Acta Biomater·2009
8-other
Intra-tumoural extra-cellular pH: a useful parameter of response to chemotherapy in syngeneic tumour lines.
PMID 19367285·Br J Cancer·2009
7-preclinical
Langmuir adsorption study of the interaction of CdSe/ZnS quantum dots with model substrates: influence of substrate surface chemistry and pH.
PMID 19053491·Langmuir·2009
8-other
Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomy.
PMID 18671791·BJU Int·2008
8-other
Systems pathology and predicting outcome after radical prostatectomy.
PMID 18711177·J Clin Oncol·2008
8-other
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.
PMID 18829513·Clin Cancer Res·2008
8-other
Prostate cancer: moving forward by reinventing the wheel...but this time it is round.
PMID 18626003·J Clin Oncol·2008
8-other
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
PMID 18086794·J Clin Oncol·2008
8-other
Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trial.
PMID 18349405·J Clin Oncol·2008
5-case
Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426).
PMID 18383517·Cancer·2008
4-observational
Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.
PMID 18577983·Nat Clin Pract Oncol·2008
6-review
Evolving perspectives of the role of novel agents in androgen-independent prostate cancer.
PMID 19468458·Indian J Urol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9500 EUCLID AVE
CLEVELAND, OH 44195 - Phone
- (800) 223-2273
Quick Facts
- NPI
- 1912961483
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile